Skip to content

A Non-Interventional Study to Compare Digital Monitoring of Patients with chronic spontaneous urticaria by Telemedicine to Face-to-Face Visits in Germany

A Non-Interventional Study to Compare Digital Monitoring of Patients with chronic spontaneous urticaria by Telemedicine to Face-to-Face Visits in Germany - DigiMoc

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00036732
Enrollment
200
Registered
2025-04-29
Start date
2024-06-11
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L50.9

Interventions

Group 1: Telemedicine Group 2: Face to Face visits

Sponsors

Novartis Pharma GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Written informed consent for participation obtained from the subject Diagnosed chronic spontaneous urticaria Medical therapy for CSU Concomitant chronic inducible urticaria is allowed Willing and be able to perform digital visits

Exclusion criteria

Exclusion criteria: simultaneous participation in any clinical trial

Design outcomes

Primary

MeasureTime frame
To quantitatively describe the frequency of UCT usage in CSU patients monitored via teledermatology compared to F2F visits.

Secondary

MeasureTime frame
To quantitatively describe the type and number of physician- patient interaction in both arms.

Countries

Germany

Contacts

Public ContactAlexander Zink

Klinikum rechts der Isar

alexander.zink@tum.de+49 89 4140 3038

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026